An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer

Clinical trial NCT00247676 · COMPLETED

Trial details

NCT number: NCT00247676
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Neoplasms Unresectable Hepatocellular Carcinoma

Start date: 2006-02-01
Primary completion: 2008-02-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.